共 12 条
- [1] Lorusso D(2024)Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial Lancet 403 1341-1350
- [2] Xiang Y(2023)Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (Outback): an international, open-label, randomised, phase 3 trial Lancet Oncol 24 468-482
- [3] Hasegawa K(2023)Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial Lancet Oncol 24 1334-1348
- [4] Mileshkin LR(2023)A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: the GCIG interlace trial Ann Oncol 34 1276-undefined
- [5] Moore KN(undefined)undefined undefined undefined undefined-undefined
- [6] Barnes EH(undefined)undefined undefined undefined undefined-undefined
- [7] Monk BJ(undefined)undefined undefined undefined undefined-undefined
- [8] Toita T(undefined)undefined undefined undefined undefined-undefined
- [9] Wu X(undefined)undefined undefined undefined undefined-undefined
- [10] McCormack M(undefined)undefined undefined undefined undefined-undefined